Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-097763
Filing Date
2024-09-06
Accepted
2024-09-06 16:34:30
Documents
2
Period of Report
2024-09-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423503-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2423503-1_4seq1.xml 4 3708
2 EXHIBIT 24.1 tm2423503d1_ex24-1.htm EX-24.1 10022
  Complete submission text file 0001104659-24-097763.txt   15260
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
CORCORAN E THOMAS (Reporting) CIK: 0001191763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 241284955